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Özet
Amaç: Acil servise başvuran yılan sokmalarının epidemiyolojik özellikleri ve 
yönetiminin değerlendirilmesi. Gereç ve Yöntem: Bu çalışmada 2008-2009 
yılları arasında Diyarbakır Eğitim ve Araştırma Hastanesi Acil Servisi’ne baş-
vuran 74 vaka retrospektif olarak değerlendirildi. Bulgular: Hastaların 46’sı 
(%62.2) erkek ve 28’i (%37.8) kadındı. Çalışmaya alınan hastaların yaş orta-
laması 34.85±19.17 (min 7- mak 80) yaştı. Yılan sokmalarının çoğu 18.00-
06.00 saatleri arasında ve evde (%73) meydana gelmişti. %79.7’si üst ekstre-
mitelerdeydi. Vakaların %93’üne tek doz intravenöz antivenin uygulandı. Has-
taların hiçbirinin tekrarlayan antivenin uygulamasına ihtiyacı olmadı. Tartış-
ma: Yılan sokmaları özellikle kırsal alanda hala büyük bir halk sağlığı sorunu-
dur. Acil servis doktorlarının yılan sokmalarına multidisipliner yaklaşımı bil-
meleri gerekmektedir.
Anahtar Kelimeler
Acil Servis; Yılan Sokması; Tedavi
Abstract
Aim: Evaluating the epidemiologic characteristics and management of snake 
bites presenting to emergency departments. Material and Method: In this 
retrospective study 74 cases of snakebites admitted to Emergency Depart-
ment of Diyarbakır Training and Research Hospital between 2008 and 2009 
were retrospectively evaluated. Results: Fourty-six (62.2%) of patients were 
male and 28 (37.8%) were female. Mean age of the study population was 
34.85±19.17 (min 7- max 80) years. Most of the snakebites occurred be-
tween 18.00 to 06.00 hours and at home (73%). 79.7% of snake bites oc-
curred to upper extremities. %93 of cases had intravenous administration 
of antivenin (one dose). Neither none of the patients needed recurrent ad-
ministration. Discussion: Snake bites are still a major public health problem 
especially in rural areas. Particularly emergency care physicians should be 
adequately capable and sophisticated in multidisciplinary management of 
snake bites.
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Çalışma Türkiye Acil Tıp Derneği’nin 2009 Antalya Kongresi’nde sözlü olarak sunulmuştur 
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Introduction
Increased urbanization and the reduction of the natural environ-
ment has not reduced the threat of animal attacks on humans. 
Contrarily they continue to be an important public health prob-
lem by creating severe medical conditions due to their toxins as 
with hymenopteras, spiders, scorpions, snakes and transmission 
of infectious agents to humans as with domestic animals like 
rabies [1,2]. 
There are 3000 venomous snake species known worldwide but 
only 200 of these are potentially life-threating for humans ow-
ing to venom characteristics or tooth structure. The venomous 
snakes include Elapidae, Viperidae, Hydrophiidae, Colubridae 
and Antractaspididae families. In Turkey 15 snake species are 
known to be poisonous [14 in the family Viperidae and one in 
the family Elapidae] and 4 are semi-venomous in the family of 
Colubridae. Geographically the climate in southeast of Turkey of 
is arid and contains mostly vipers, especially Vipera lebetina and 
Vipera xanthina, as most venomous snakes [3, 4, 5, 6].
The clinical picture of a snake bite can include symptoms and 
signs secondary to cytotoxic, hypotensive, neurotoxic, or antico-
agulant effects of the specific snake venom or the course after 
the attack can be limited to a sole dry bite without systemic or 
local symptoms when the snake cannot inject its venom [3,4].
Conventional management of snake bites includes supportive 
care (fluid infusion, analgesic drugs, antibiotics, elevation of ex-
tremities) and antivenom therapy, the latter being the corner-
stone of management [3].
We aimed in this study to investigate the demographic and 
clinical properties and outcomes of patients admitting to emer-
gency department with snake bite and to review the available 
treatment approaches.
Material and Method
In this study 74 patients suffering from snakebite who were 
admitted to the Emergency Department of Diyarbakır Training 
and Research Hospital between 2008 and 2009 were retrospec-
tively evaluated. Besides demographical data the time periods 
of the bites occurred, type of the bite, area of the body bitten, 
the presence of symptoms suggesting systemic toxicity, local 
symptoms and antivenom use were analyzed. Because almost 
all of the bites were quick and defensive the exact snake species 
could not be identified. 
All patients were evaluated in terms of severity of envenom-
ation due to Grade 1-4 scoring method and that means sever-
ity of the reaction to the snakebite depends on the degree of 
envenomation [7, 8]. 
Statistical analyses of the study data were performed with the 
help of the Statistical Package for the Social Sciences (SPSS) 
v. 16.0 software package. Descriptive data were expressed as 
frequency and percentage.
Results
A total of 74 snakebite patients were analyzed in the 2 year 
period from January 2008 to December 2009. 46 (62.2%) of 
these were male and 28 (37.8%) were female. Mean age of the 
study population was 34.85±19.17 (min 7-max 80) years. Male 
to female ratio was 1.64. Most of the snakebites occurred be-
tween 18.00 to 06.00 hours and at home (73%). Regarding the 
bite sites, 59 patients (79.7%) were bitten from their hands, 
whereas 12 (16.2%) were bitten from their foot and 3 were bit-
ten from the other sides of their body (face and trunk). All char-
acteristics of cases were summarized in Table 1.
The most common complaints at presentation were pain, ery-
tema and edema (swelling). Five (6.8%) of the patients had dry 
bites at iniatially and 4 of them developed to Grade 0 envenom-
ation during their observation (Tablo 2). 
On admission after examining the bite site and performing 
wound care; prophylaxis with tetanus toxoid and/or tetanus 
immune globulin at a dosage of 250 IU intramuscularly was 
administered all of the patients, the injured extremity was im-
mobilized and elevation was performed. All cases received sup-
portive and symptomatic treatment with analgesics, antialler-
gics, mild sedatives and fluid resuscitation. 
Except the 5 dry bites remainder of cases had intravenous ad-
ministration of antivenin (one dose). During emergency depart-
ment observation 4 of 5 dry bites who developed local symp-
Table 1. Baseline and epidemiological characteristics of patient
Characteristics  n (%)
Gender Male 46 (62.2)
Female 28 (37.8)
Age Pediatric 15 (20.27)
Adult 59 (79.73)
District Urban 22 (29.7)
Rural 52 (70.3)
Bite months April 4 (5.4) 
May-July 35 (47.29)
June-August 31 (41.89)
September-October 4 (5.4)
Bite hours 06.00-18.00 31 (41.9)
18.00-06.00 43 (58.1)
Place where the bite occured Indoor 54 (73) 
Outdoor 20 (27)
Bite site Upper extremity 59 (79.7)
Lower extremity 12 (16.2)
Face 2 (2.7)
Trunk 1 (1.3)
Table 2. Severity of the snakebite according to the Grade 1-4 scoring system
Grade    n  %
0 no 
envenomation 
Fang marks, minimal pain, swelling 
and erythema around the fang 
marks <2.5 cm, no systemic 
sypmtoms
 6  8.1
I Minimal 
envenomation
Fang marks, immediate pain, 
swelling and erythema of 2.5-15 
cm during the first 12 hours, no 
systemic signs
 67  90.5
II Moderate 
envenomation
Fang marks, immediate severe 
pain,swelling and erythema of 15-
40 cm during the first 12 hours, 
mild systemic signs
 _
III Severe 
envenomation
Fang marks, immediate severe 
pain,swelling and erythema >40 
cm in the first 12 hours with 
systemic signs
 _
IV Very severe 
envenomation
Fang marks, immediate severe 
pain, severe systemic signs 
including shock and coma, 
 _
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toms had also one dose antivenin treatment. Neither none of 
the patients needed recurrent administration of antivenin nor 
developed complications of antivenin administration.
Discussion
Snake bite is a public health issue, particularly in rural popula-
tions with low socioeconomic level, which is often neglected. 
Certain factors such as climate conditions, ecological charac-
teristics, biodiversity, geographical distribution of venomous 
snakes, density of human population, economic activities, and 
types of human dwellings affect the reported rates of snake 
bites in a given geographic region. Although it is not entirely 
known how many snake bites occur annually, estimates suggest 
that it occurs to 1,2-5 million people each year with up to 421 
thousand to 1.8 million envenomings [9, 10]. 
Currently, snake bites have become an occupational disease in 
developing countries because automatization and mechaniza-
tion of agriculture has reduced the rates of snake bites. The 
incidents most commonly occur accidentally from close encoun-
ter between humans and snakes when snakes have no time to 
flee away, are crushed inadvertently, or feel threatened. Indeed, 
most snake species do not exhibit aggressive behavior to hu-
mans with a few exceptions [3, 11, 12]. ,
From a demographic point of view, men are more than two 
times at increased risk of being bitten by a snake than women 
and preschool children (age 0–5) are relatively spared, although 
snake bites are seen at all ages [13, 14]. In agreement with 
literature, in our study the number of male patients was higher 
than that of females and there were no preschool children, with 
the youngest victim being 7 years old (Table 1).
Snakes have a seasonal life cycle. They lose body temperature 
and are unable to regulate it at cold weather and hence they 
become stiffer, their movement ability is reduced and their me-
tabolism slows down. Thus, they hibernate in pits, crevices to 
protect themselves from cold in winter. Their body temperature 
starts to increase with temperature rise in spring, and they re-
turn to their natural environment in summer when their me-
tabolism is fully activated. Therefore, majority of snake bites 
are seen in summer months when both humans and snakes are 
active outdoors [15]. In a study from Southeastern Anatolia re-
gion [7] it was reported that all snake bites occurred between 
April and October. Another study from Diyarbakır reported that 
the cases were distributed between May and September [14]. 
Another study from Diyarbakır about reptiles indicated that 
people generally sleep on the roof and balcony or in the summer 
house because of the excessive heat between June and August, 
and the incidence of stings higher during this time period [16]. 
Similarly, we observed that all of our cases occurred between 
April and September. This is because the temperature ranges 
between 35 to 50 degrees celsius in summer, which is in com-
pliance with snakes’ seasonal pattern. We also observed that 
58.1% of our cases occurred at evening or night (between 18:00 
and 06:00) as mentioned in the literature (Table1).
Snake venom is composed of an admixture of pharmacologi-
cally active enzymatic and non-enzymatic protein and peptide 
toxins. Snake venom contains more than 20 separate enzymes. 
However, each snake species have a unique venom composition. 
The elapids predominantly contain neurotoxins while vipers se-
crete venoms with cytotoxic and anticoagulant ⁄ procoagulant 
properties and venoms of Viperidae family is usually associated 
with hematologic effects exerted by protease inhibitors, factor 
X activators, protein C activators and disintegrins. Apart from 
systemic effects, venoms cause local tissue damage through 
TNFα, phospholipase A2, and xantine oxidase mediated inflam-
matory response [14, 17, 18].
The clinical picture following a snake bite may be either in the 
form of a “dry bite” where the snake is not venomous or has no 
chance to inject its venom, or local or systemic signs and symp-
toms depending on pharmacologic actions of combined effects 
of toxic and non-toxic components of the venom. All snake bites 
appear as a dry wound on skin but the snake envenomation is a 
dynamic process. Factors influencing the severity of snake en-
venomation include patient age, the bitten body region, activity 
of the patient after the incident, the length of the snake, the 
size of the venom sac of the snake, the injected venom dose and 
its strength, and the diffusion rate at which the venom enters 
general circulation. Nevertheless, identical bites may produce 
greatly different systemic toxicity signs depending on the pa-
tient’s body mass [4, 8, 19]. In our study 6.8% of the patients 
had a dry bite at the time of admission, with 4 of them develop-
ing local symptoms during their emergency service follow-up. 
This shows that snake envenomation is a dynamic process. 
Hands and upper extremities are the subject of snake bites in 
about two thirds of all incidents [5]. However, one study report-
ed that snake bites more commonly occurred on lower extremi-
ties [12]. Although there are conflicting results in literature with 
regard to rates of upper and lower extremity envenomations, 
snake bites occur more frequently in extremities, most com-
monly feet, hands, and arms .[12, 14]. We also observed that 
79.7% of snake bites occurred to upper extremities.
The local inflammation and toxicity is the earliest manifestation 
of a snake bite, which occurs within 5-8 minutes and includes 
local pain with radiation as the earliest symptom. This is fol-
lowed by tissue swelling, bleeding, myonecrosis, and ultimately 
tissue softening due to snake venom, especially of viper family. 
The entire limb may be swollen and a resultant compartment 
syndrome may ensue [19].
Systemic signs and symptoms following a snake bite may in-
clude tachycardia, bradycardia, arterial hypotension, shock, 
nausea-vomiting, sweating, abdominal pain, diarrhea, cardiac 
ischemia and arrhythmias, rhabdomyolysis, and acute renal fail-
ure. Especially viperidae family may cause diffuse thrombosis 
and bleeding all over the body owing to their venom effective 
on the coagulation cascade and thrombocyte functions [20, 21]. 
Neurological manifestations caused particularly by elapidae 
and sometimes viperidae include cerebral hypoxia, stroke, neu-
romuscular disorder as a result of peripheral nerve injuries, and 
convulsions [3]. Almost all patients in our study had local signs 
specific to Grade I (pain, erythema, edema, tingling, numbness) 
but none had systemic signs. 
The treatment process should preferentially begin with an as-
sessment of the severity of poisoning in conjunction with a 
clinical staging using vital signs at admission (blood pressure, 
pulse rate, number of respiration), local tissue signs, presence 
of systemic signs and laboratory data [3, 22].
Routine tetanus immunization is recommended. A major compli-
|  Journa  of C inical and Analytical Medicine560
 | Journal of Clinical and Analytical Medicine
Snake Bite / Yılan Sokması
4
cation of snake bites with local effects is soft tissue infections 
that result from extensive tissue destruction and necrosis as a 
result of the proteolytic properties of the venom. This creates 
tendency to local infections from snake’s oral flora. Despite the 
fact that bacteria frequently cause wound infection following 
snake bites, the benefits of prophylactically given antibiotics is 
still controversial. Even so, wide-spectrum antibiotics effective 
against S.Aureus and anaerobes can be used prophylactically 
to prevent colonization, although such a practice is doubted in 
Grade 0 and 1 [3, 22, 23].
The cornerstone of the treatment of snake bite envenoming 
is antivenoms of animal origin. These agents are produced by 
immunization of certain animals, most commonly horses, with 
venom of a single or multiple medically-relevant snake species. 
This therapy has substantially reduced mortality rate of snake 
envenomations but since it is also associated with certain com-
plications and side effects, it should be used only in patients 
with systemic signs of envenomation. In severe cases, antiven-
oms are vital. Repeated doses may sometimes be required ow-
ing to delayed absorption of the venom from the bite site to 
general circulation, a condition called recurrent envenomation 
[3, 24]. There are three commercially available antivenoms in 
Turkey: (i) “European Viper Venom®” (Intervax Biological Ltd., 
Toronto, Zagreb, Croatia), (ii) “Pasteur Ipser Europe®” (Pasteur 
Merieux, Lyon, France) and (iii) “Polyvalent Snake Venom Antise-
rum®” (Vacsera, Giza, Egypt) [5].
The affected limb should be absolutely brought under close 
monitorization to decrease the severity of tissue necrosis. The 
diameter of the affected extremity below and above the level 
of snake bite site should be measured every 15 minutes until 
swelling vanishes. Serial measurement of compartment pres-
sures may prove useful against development of compartment 
syndrome. In case of tissue necrosis, debridement is indicated; 
however, fasciotomy is only rarely required [25]. 
Symptomatic treatment of snake bite victims include antiemet-
ics and antihistaminics; hemorrhage fresh frozen plasma, cryo-
precipitate, and platelet infusions may be used; hypotensive 
patients are treated with crystalloids and/or vasopressors; pain 
management include non-steroidal anti-inflammatory drugs; 
muscle spasms and seizures require calcium gluconate. In such 
patients adequate respiration should be maintained [20].
Conclusion
As the rest of the world, snake bites are also a major public 
health problem in Turkey with regard to their mortality and 
morbidity risks. Management of these medical emergencies re-
quires a multidisciplinary approach. Particularly emergency care 
physicians should be familiar with but most importantly excel in 
the management of snake bites.
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